Dr. Kattakuzhy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1900 Massachusetts Ave SE
# 29
Washington, DC 20003Phone+1 202-548-6541Fax+1 202-548-6534
Education & Training
- George Washington UniversityResidency, Internal Medicine, 2009 - 2012
- Eastern Virginia Medical SchoolClass of 2009
Certifications & Licensure
- MD State Medical License 2013 - 2026
- DC State Medical License 2009 - 2022
- VA State Medical License 2009 - 2012
- American Board of Preventive Medicine Addiction Medicine
Clinical Trials
- Safety and Preliminary Efficacy of ANS-6637 to Reduce Drug Craving and Harm in People With Opioid Use Disorder Start of enrollment: 2021 Jan 01
Publications & Presentations
PubMed
- Elevated rate of suicide risk in individuals with opioid use disorder.Max Spaderna, Elana Rosenthal, Sun Jung Kang, Rahwa Eyasu, Emade Ebah
The American Journal on Addictions. 2025-03-11 - A Sequential Mixed-Methods Study of Factors Associated with Low High-Resolution Anoscopy Completion in Transgender Women with Abnormal Anal Cytology.Omar Harfouch, Darren Whitfield, Tural Mammadli, Rahwa Eyasu, Connor Volpi
AIDS Patient Care and Stds. 2025-02-01 - 1 citationsHigh Rates of High-risk HPV Anal Infection and Abnormal Cytology in a Cohort of Transgender People Assigned Male at Birth.Omar Harfouch, Andrea Lisco, Habib Omari, Rahwa Eyasu, Ashley Davis
Open Forum Infectious Diseases. 2024-12-01
Press Mentions
- Allyship in Action at the 2025 UMBrella SymposiumMarch 21st, 2025
- Leaders in Health Care 2022: Dr. Sarah Kattakuzhy and Dr. Elana Rosenthal, UM School of MedicineOctober 7th, 2022
- NIH to Test Experimental Drug to Curb Drug CravingsMarch 22nd, 2019
- Join now to see all
Grant Support
- ARTEMIS: Advancing Addiction Research and Treatment through Engagement with Rural Marylanders Impacted by PolySubstance UseUNIVERSITY OF MARYLAND BALTIMORE2024–2029
- Evaluating the role of stigma in polysubstance use and medication for opioid use disorder treatment in an underserved, rural settingUNIV OF MARYLAND, COLLEGE PARK2022–2025
- CJ-PRISM: Understanding the Impact of Criminolegal System Involvement on a Peer-Delivered Intervention to Improve Retention and Polysubstance UseUNIV OF MARYLAND, COLLEGE PARK2022–2025
- CJ-PRISM: Understanding the Impact of Criminolegal System Involvement on a Peer-Delivered Intervention to Improve Retention and Polysubstance UseUNIV OF MARYLAND, COLLEGE PARK2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: